Among these genes, ZEB2 was reported to mediate crosstalk between TGFβ signaling and the EMT pathway [38], which further emphasizes the tumor‐promoting activity of TGFβ signaling and the therapeutic role of TGFβ blockade in the SCS2 subtype. This evidence concerns the gene TGFB1 and neoplasm.